Biotech and Pharma Stocks

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

Amplia Therapeutics证实抗癌药物AMP945可以抑制健康志愿者的局灶黏着激酶

Amplia Therapeutics confirms anti-cancer drug AMP945 can inhibit focal adhesion kinase in healthy volunteers

Invion将筹集1500万澳元用于正在进行的Photosoft技术开发和扩大市场

Invion to raise $15m to fund ongoing Photosoft technology development and expand market reach

随着收入激增，Montu筹集资金推进医用大麻远程保健平台

Montu raises funds to advance medical cannabis telehealth platform as revenue surges

Aegros的HaemaFrac血浆馏分工艺为抵御COVID-19和其他疾病提供了新的防御手段

Aegros’ HaemaFrac plasma fraction process offers new defence against COVID-19 and other diseases

Invex Therapeutics chases global registration of Presendin to treat idiopathic intracranial hypertension

Invex Therapeutics寻求Presendin的全球注册，以治疗特发性颅内高压

Argenica Therapeutics reveals positive pre-clinical results of stroke drug ARG-007 in HIE

Argenica Therapeutics显示卒中药物ARG-007在HIE中的临床前结果呈阳性

ECS Botanics raises $6.6m to accelerate growth after record September quarter

ECS Botanics在9月份创纪录的季度后筹集了660万澳元以加速增长

Greenlab为帮助发展新西兰药用大麻产业提供了联合资助

Greenlab awarded co-funding grant to help grow New Zealand’s medicinal cannabis industry

研究表明，Invion的INV043可以治愈三阴性乳腺癌肿瘤

Study shows Invion’s INV043 could regress triple negative breast cancer tumours

Incannex Healthcare获得IND前指导和伦理批准，开始2a期迷幻药试验

Incannex Healthcare receives pre-IND guidance and ethics approval to begin phase 2a psychedelic trial

Amplia Therapeutics聘请著名肿瘤药物开发专家担任临床顾问